ScholarIQanswers from OpenAlex
Alexion Pharmaceuticals (United States)
InstitutionResearch output, impact & collaborations
Alexion Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Alexion Pharmaceuticals (United States)?
ScholarIQrecord summary
Alexion Pharmaceuticals (United States) is a research organisation in Boston, US. OpenAlex records 1,356 works and 169,643 citations for it. 466 researchers list it as their most recent affiliation.
How many works does Alexion Pharmaceuticals (United States) have?
ScholarIQindexed works
Alexion Pharmaceuticals (United States) has 1,356 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alexion Pharmaceuticals (United States) have?
ScholarIQcitation count
Alexion Pharmaceuticals (United States) has 169,643 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Alexion Pharmaceuticals (United States)?
ScholarIQresearcher count
Alexion Pharmaceuticals (United States) has 466 researchers in the ScholarIQ index.
What is the average h-index at Alexion Pharmaceuticals (United States)?
ScholarIQavg h-index
Alexion Pharmaceuticals (United States) has an average h-index of 33.7 in OpenAlex.
What is the ROR of Alexion Pharmaceuticals (United States)?
ScholarIQror
The ROR for Alexion Pharmaceuticals (United States) is on the source record.
What is the OpenAlex record for Alexion Pharmaceuticals (United States)?
ScholarIQopenalex
The OpenAlex for Alexion Pharmaceuticals (United States) is on the source record.
Who are the most-cited researchers behind Alexion Pharmaceuticals (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Alexion Pharmaceuticals (United States)?
ScholarIQmost cited works
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham, Jennifer Clay Cather, Jamie Weisman, David M. Pariser, Eric L. Simpson, Kim Papp, Hyuck-Ki Hong, Diana Rubel, Peter Foley, Errol P. Prens, C.E.M. Griffiths, Takafumi Etoh, Pedro Herranz, Ramón M. Pujol, Jacek C. Szepietowski, Karel Ettler, Lajos Kemény, Xiaoping Zhu, Bolanle Akinlade, Thomas Hultsch, Vera Mastey, Abhijit Gadkari, Laurent Eckert, Nikhil Amin, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Brad Shumel
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, Jorge Máspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D. Hamilton, Brian N. Swanson, Asif Khan, Jingdong Chao, Heribert Staudinger, Gianluca Pirozzi, Christian Antoni, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Ariel Teper
How much of the research on Alexion Pharmaceuticals (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS